Fact Sheet Ovarian Cysts
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Bartholin's Cyst, Also Called a Bartholin's Duct Cyst, Is a Small Growth Just Inside the Opening of a Woman’S Vagina
Saint Mary’s Hospital Bartholin’s cyst Information For Patients 2 Welcome to the Gynaecology Services at Saint Mary’s Hospital This leaflet aims to give you some general information about Bartholin’s cysts and help to answer any questions you may have. It is intended only as a guide and there will be an opportunity for you to talk to your nurse and doctor about your care and treatment. What is a Bartholin;s cyst? A Bartholin's cyst, also called a Bartholin's duct cyst, is a small growth just inside the opening of a woman’s vagina. Cysts are small fluid-filled sacs that are usually harmless. Normal anatomy Bartholin gland cyst Bartholin’s glands The Bartholin’s glands are a pair of pea-sized glands that are found just behind and either side of the labia minora (the inner pair of lips surrounding the entrance to the vagina). The glands are not usually noticeable because they are rarely larger than 1cm (0.4 inches) across. 3 The Bartholin’s glands secrete fluid that acts as a lubricant during sexual intercourse. The fluid travels down tiny ducts (tubes) that are about 2cm (0.8 inches) long into the vagina. If the ducts become blocked, they will fill with fluid and expand. This then becomes a cyst. How common is a Bartholin’s cyst? According to estimates, around 2% (1 in 50) of women will experience a Bartholin’s cyst at some point. The condition usually affects sexually active women between the ages of 20 and 30. The Bartholin’s glands do not start functioning until puberty, so Bartholin’s cysts do not usually affect children. -
About Ovarian Cancer Overview and Types
cancer.org | 1.800.227.2345 About Ovarian Cancer Overview and Types If you have been diagnosed with ovarian cancer or are worried about it, you likely have a lot of questions. Learning some basics is a good place to start. ● What Is Ovarian Cancer? Research and Statistics See the latest estimates for new cases of ovarian cancer and deaths in the US and what research is currently being done. ● Key Statistics for Ovarian Cancer ● What's New in Ovarian Cancer Research? What Is Ovarian Cancer? Cancer starts when cells in the body begin to grow out of control. Cells in nearly any part of the body can become cancer and can spread. To learn more about how cancers start and spread, see What Is Cancer?1 Ovarian cancers were previously believed to begin only in the ovaries, but recent evidence suggests that many ovarian cancers may actually start in the cells in the far (distal) end of the fallopian tubes. 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 What are the ovaries? Ovaries are reproductive glands found only in females (women). The ovaries produce eggs (ova) for reproduction. The eggs travel from the ovaries through the fallopian tubes into the uterus where the fertilized egg settles in and develops into a fetus. The ovaries are also the main source of the female hormones estrogen and progesterone. One ovary is on each side of the uterus. The ovaries are mainly made up of 3 kinds of cells. Each type of cell can develop into a different type of tumor: ● Epithelial tumors start from the cells that cover the outer surface of the ovary. -
Prohibitin-Induced Obesity Leads to Anovulation and Polycystic Ovary in Mice Sudharsana Rao Ande1,*, Khanh Hoa Nguyen1,*, Yang Xin Zi Xu1 and Suresh Mishra1,2,‡
© 2017. Published by The Company of Biologists Ltd | Biology Open (2017) 6, 825-831 doi:10.1242/bio.023416 RESEARCH ARTICLE Prohibitin-induced obesity leads to anovulation and polycystic ovary in mice Sudharsana Rao Ande1,*, Khanh Hoa Nguyen1,*, Yang Xin Zi Xu1 and Suresh Mishra1,2,‡ ABSTRACT and Dunphy, 2014). Along with the increase in the prevalence of Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder overweight and obesity in women, there has been an increase in and the most common cause of female infertility. However, its etiology anovulatory infertility (Giviziez et al., 2016). Androulakis et al. and underlying mechanisms remain unclear. Here we report that a (2014) reported that visceral adiposity index is related to the severity transgenic obese mouse (Mito-Ob) developed by overexpressing of anovulation and other clinical features in women with polycystic prohibitin in adipocytes develops polycystic ovaries. Initially, the ovaries. An increase in subcutaneous abdominal fat has also been female Mito-Ob mice were equally fertile to their wild-type littermates. associated with anovulation in women with obesity (Kuchenbecker The Mito-Ob mice began to gain weight after puberty, became et al., 2010). It is believed that anovulatory infertility accounts for significantly obese between 3-6 months of age, and ∼25% of them 25-50% of causes of female infertility (Weiss and Clapauch, 2014). had become infertile by 9 months of age. Despite obesity, female One of the main causes of anovulatory infertility is polycystic Mito-Ob mice maintained glucose homeostasis and insulin sensitivity ovaries (Ben-Shlomo et al., 2008; Messinis et al., 2015). -
Diagnostic Approach to Congenital Cystic Masses of the Neck from a Clinical and Pathological Perspective
Review Diagnostic Approach to Congenital Cystic Masses of the Neck from a Clinical and Pathological Perspective Amanda Fanous 1,†, Guillaume Morcrette 2,†, Monique Fabre 3, Vincent Couloigner 1,4 and Louise Galmiche-Rolland 5,* 1 Pediatric Otolaryngology-Head and Neck Surgery, AP-HP, Hôpital Universitaire Necker Enfants Malades, 75015 Paris, France; [email protected] (A.F.); [email protected] (V.C.) 2 Department of Pediatric Pathology, AP-HP, Hôpital Robert Debré, 75019 Paris, France; [email protected] 3 Department of Pathology, AP-HP, Hôpital Universitaire Necker Enfants Malades, Université Paris Descartes, 75015 Paris, France; [email protected] 4 Faculté de Médecine, Université de Paris, 75015 Paris, France 5 Department of Pathology, University Hospital of Nantes, 44000 Nantes, France * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: Background: neck cysts are frequently encountered in pediatric medicine and can present a diagnostic dilemma for clinicians and pathologists. Several clinical items enable to subclassify neck cyst as age at presentation, anatomical location, including compartments and fascia of the neck, and radiological presentation. Summary: this review will briefly describe the clinical, imaging, pathologi- cal and management features of (I) congenital and developmental pathologies, including thyroglossal duct cyst, branchial cleft cysts, dermoid cyst, thymic cyst, and ectopic thymus; (II) vascular malforma- Citation: Fanous, A.; Morcrette, G.; Fabre, M.; Couloigner, V.; tions, including lymphangioma. Key Messages: pathologists should be familiar with the diagnostic Galmiche-Rolland, L. Diagnostic features and clinicopathologic entities of these neck lesions in order to correctly diagnose them and Approach to Congenital Cystic to provide proper clinical management. -
ISUOG Basic Training Examining the Uterus, Cervix, Ovaries and Adnexae: Abnormal Findings
ISUOG Basic Training Examining the Uterus, Cervix, Ovaries and Adnexae: Abnormal Findings Douglas Dumbrill, South Africa EditableBasic training text here Learning objective At the end of the lecture you will be able to: • compare the differences between typical normal and common abnormal appearances presenting in gynecological ultrasound examinations EditableBasic training text here Key questions • How do the ultrasound appearances of fibroids and adenomyosis differ? • What are the typical ultrasound appearances of the most common endometrial and intracavitary pathologies? • What are the typical ultrasound appearances of the most common pathologies in the adnexae? • How do I describe my ultrasound findings using the standardized IOTA and IETA terminology? • Which patients should I refer for specialist opinion? EditableBasic training text here The basis for ultrasound diagnosis in gynecology • Gray scale ultrasound • To use Doppler ultrasound, you must – be familiar with Doppler physics – understand the pitfalls of Doppler ultrasound – recognize Doppler artefacts • Doppler settings must be correct – Pulse repetition frequency (PRF) 0.3- 0.6 KHz EditableBasic training text here Common myometrial pathology • Myoma • Adenomyosis EditableBasic training text here Most common myometrial pathology - myoma Round, oval or lobulated solid tumor casting stripy shadows EditableBasic training text here Hyperechogenic uterine myoma EditableBasic training text here Cystically degenerated myomas EditableBasic training text here Typical myoma Round, oval -
American Family Physician Web Site At
Diagnosis and Management of Adnexal Masses VANESSA GIVENS, MD; GREGG MITCHELL, MD; CAROLYN HARRAWAY-SMITH, MD; AVINASH REDDY, MD; and DAVID L. MANESS, DO, MSS, University of Tennessee Health Science Center College of Medicine, Memphis, Tennessee Adnexal masses represent a spectrum of conditions from gynecologic and nongynecologic sources. They may be benign or malignant. The initial detection and evaluation of an adnexal mass requires a high index of suspicion, a thorough history and physical examination, and careful attention to subtle historical clues. Timely, appropriate labo- ratory and radiographic studies are required. The most common symptoms reported by women with ovarian cancer are pelvic or abdominal pain; increased abdominal size; bloating; urinary urgency, frequency, or incontinence; early satiety; difficulty eating; and weight loss. These vague symptoms are present for months in up to 93 percent of patients with ovarian cancer. Any of these symptoms occurring daily for more than two weeks, or with failure to respond to appropriate therapy warrant further evaluation. Transvaginal ultrasonography remains the standard for evaluation of adnexal masses. Findings suggestive of malignancy in an adnexal mass include a solid component, thick septations (greater than 2 to 3 mm), bilaterality, Doppler flow to the solid component of the mass, and presence of ascites. Fam- ily physicians can manage many nonmalignant adnexal masses; however, prepubescent girls and postmenopausal women with an adnexal mass should be referred to a gynecologist or gynecologic oncologist for further treatment. All women, regardless of menopausal status, should be referred if they have evidence of metastatic disease, ascites, a complex mass, an adnexal mass greater than 10 cm, or any mass that persists longer than 12 weeks. -
Prohibitin-Induced Obesity Leads to Anovulation and Polycystic Ovary in Mice
Prohibitin-induced obesity leads to anovulation and polycystic ovary in mice Sudharsana Rao Ande†1, Khanh Hoa Nguyen†1, Yang Xin Zi Xu1, Suresh Mishra*1,2 Department of Internal Medicine1, Department of Physiology & Pathophysiology2, University of Manitoba, Winnipeg, Canada Key words: Transgenic models, periovarian adipose tissue, cystic ovary, female infertility. † Contributed equally to this manuscript. * Correspondence Suresh Mishra, Ph.D. Department of Internal Medicine University of Manitoba Rm 843, John Buhler Research Centre 715 McDermot Avenue Winnipeg, MB R3E 3P4 Canada Ph. 204 977 5629 Fax: 204 789 3988 E-mail: [email protected] © 2017. Published by The Company of Biologists Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction Biology Open • Advance article in any medium provided that the original work is properly attributed. ABSTRACT Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder and the most common cause of female infertility. However, the etiology of the disease and the mechanisms by which this disorder progress remain unclear. Here we report that a transgenic obese mouse (Mito-Ob) developed by overexpressing prohibitin in adipocytes develops polycystic ovaries. Initially, the female Mito-Ob mice were equally fertile to their wild-type littermates. Mito-Ob mice begin to gain weight after puberty, become significantly obese between 3-6 months of age, and roughly 25% of them become infertile by 9 months of age. Despite obesity, female Mito-Ob mice maintained glucose homeostasis and insulin sensitivity similar to their wild- type littermates. -
Practical Applications of Molecular Testing in the Cytologic Diagnosis of Pancreatic Cysts
Review Practical Applications of Molecular Testing in the Cytologic Diagnosis of Pancreatic Cysts Mingjuan Lisa Zhang * and Martha B. Pitman * Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA * Correspondence: [email protected] (M.L.Z.); [email protected] (M.B.P.) Abstract: Mucinous pancreatic cysts are precursor lesions of ductal adenocarcinoma. Discoveries of the molecular alterations detectable in pancreatic cyst fluid (PCF) that help to define a mucinous cyst and its risk for malignancy have led to more routine molecular testing in the preoperative evaluation of these cysts. The differential diagnosis of pancreatic cysts is broad and ranges from non-neoplastic to premalignant to malignant cysts. Not all pancreatic cysts—including mucinous cysts—require surgical intervention, and it is the preoperative evaluation with imaging and PCF analysis that determines patient management. PCF analysis includes biochemical and molecular analysis, both of which are ancillary studies that add significant value to the final cytological diagnosis. While testing PCF for carcinoembryonic antigen (CEA) is a very specific test for a mucinous etiology, many mucinous cysts do not have an elevated CEA. In these cases, detection of a KRAS and/or GNAS mutation is highly specific for a mucinous etiology, with GNAS mutations supporting an intraductal papillary mucinous neoplasm. Late mutations in the progression to malignancy such as those found in TP53, p16/CDKN2A, and/or SMAD4 support a high-risk lesion. This review highlights PCF triage and analysis of pancreatic cysts for optimal cytological diagnosis. Keywords: pancreatic cytology; pancreatic cyst fluid; cyst fluid triage; molecular testing; mucinous cyst; intraductal papillary mucinous neoplasm; mucinous cystic neoplasm Citation: Zhang, M.L.; Pitman, M.B. -
Grading Pelvic Prolapse and Pelvic Floor Relaxation Using Dynamic Magnetic Resonance Imaging
ADULT UROLOGY GRADING PELVIC PROLAPSE AND PELVIC FLOOR RELAXATION USING DYNAMIC MAGNETIC RESONANCE IMAGING CRAIG V. COMITER, SANDIP P. VASAVADA, ZORAN L. BARBARIC, ANGELO E. GOUSSE, AND SHLOMO RAZ ABSTRACT Objectives. With significant vaginal prolapse, it is often difficult to differentiate among cystocele, enterocele, and high rectocele by physical examination alone. Our group has previously demonstrated the utility of magnetic resonance imaging (MRI) for evaluating pelvic prolapse. We describe a simple objective grading system for quantifying pelvic floor relaxation and prolapse. Methods. One hundred sixty-four consecutive women presenting with pelvic pain (n ϭ 39) or organ prolapse (n ϭ 125) underwent dynamic MRI. The “H-line” (levator hiatus) measures the distance from the pubis to the posterior anal canal. The “M-line” (muscular pelvic floor relaxation) measures the descent of the levator plate from the pubococcygeal line. The “O” classification (organ prolapse) characterizes the degree of visceral prolapse beyond the H-line. Results. The image acquisition time was 2.5 minutes per study. Each study cost $540. In the pain group, the H-line averaged 5.2 Ϯ 1.1 cm versus 7.5 Ϯ 1.5 cm in the prolapse group (P Ͻ0.001). The M-line averaged 1.9 Ϯ 1.2 cm in the pain group versus 4.1 Ϯ 1.5 cm in the prolapse group (P Ͻ0.001). Incidental pelvic pathologic features were commonly noted, including uterine fibroids, ovarian cysts, hydroureter, urethral diverticula, and foreign body. Conclusions. The HMO classification provides a straightforward and reproducible method for staging and quantifying pelvic floor relaxation and visceral prolapse. -
Ovarian Cysts
Midlands Family Medicine 611 West Francis St. Suite 100 North Platte, NE 69101 Phone: (308) 534-2532 Fax: (308) 534-6615 Education Ovarian Cysts What are ovarian cysts? Ovarian cysts are fluid-filled sacs in or on an ovary. The two ovaries are part of the female reproductive system. They produce eggs and the female hormones estrogen and progesterone. How do they occur? Ovarian cysts are common and occur in two types: functional and abnormal. Functional cysts are quite normal. They may develop as a result of the normal functions of an ovary. The most common types of functional cysts are follicular and corpus luteum cysts: A follicular cyst forms when the follicle of an ovary gets bigger and fills with fluid as it produces an egg. A corpus luteum cyst occurs after an egg has been released from the follicle. If pregnancy does not occur, the corpus luteum usually disintegrates. However, occasionally it swells with fluid or blood and remains on the surface of the ovary as a cyst. Functional cysts should not occur after menopause. Abnormal cysts result from abnormal cell growth. Sometimes abnormal cysts are caused by cancer, but 95% of cysts are not cancerous. The most common abnormal cysts are dermoid cysts. These cysts are similar to skin tissue on the outside and are filled with fatty material and sometimes bits of bone, hair, nerve tissue, and cartilage. You have a higher risk for getting an ovarian cyst if: You have pelvic inflammatory disease (PID). You have endometriosis. You have bulimia. You are taking a drug for epilepsy called valproate. -
Non-Cancerous Breast Conditions Fibrosis and Simple Cysts in The
cancer.org | 1.800.227.2345 Non-cancerous Breast Conditions ● Fibrosis and Simple Cysts ● Ductal or Lobular Hyperplasia ● Lobular Carcinoma in Situ (LCIS) ● Adenosis ● Fibroadenomas ● Phyllodes Tumors ● Intraductal Papillomas ● Granular Cell Tumors ● Fat Necrosis and Oil Cysts ● Mastitis ● Duct Ectasia ● Other Non-cancerous Breast Conditions Fibrosis and Simple Cysts in the Breast Many breast lumps turn out to be caused by fibrosis and/or cysts, which are non- cancerous (benign) changes in breast tissue that many women get at some time in their lives. These changes are sometimes called fibrocystic changes, and used to be called fibrocystic disease. 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 Fibrosis and cysts are most common in women of child-bearing age, but they can affect women of any age. They may be found in different parts of the breast and in both breasts at the same time. Fibrosis Fibrosis refers to a large amount of fibrous tissue, the same tissue that ligaments and scar tissue are made of. Areas of fibrosis feel rubbery, firm, or hard to the touch. Cysts Cysts are fluid-filled, round or oval sacs within the breasts. They are often felt as a round, movable lump, which might also be tender to the touch. They are most often found in women in their 40s, but they can occur in women of any age. Monthly hormone changes often cause cysts to get bigger and become painful and sometimes more noticeable just before the menstrual period. Cysts begin when fluid starts to build up inside the breast glands. Microcysts (tiny, microscopic cysts) are too small to feel and are found only when tissue is looked at under a microscope. -
A Novel SRY Missense Mutation Affecting Nuclear Import in a 46,XY Female Patient with Bilateral Gonadoblastoma
European Journal of Human Genetics (2009) 17, 1642 – 1649 & 2009 Macmillan Publishers Limited All rights reserved 1018-4813/09 $32.00 www.nature.com/ejhg ARTICLE A novel SRY missense mutation affecting nuclear import in a 46,XY female patient with bilateral gonadoblastoma Remko Hersmus1, Bertie HCGM de Leeuw1, Hans Stoop1, Pascal Bernard2, Helena C van Doorn3, Hennie T Bru¨ggenwirth4, Stenvert LS Drop5, J Wolter Oosterhuis1, Vincent R Harley2 and Leendert HJ Looijenga*1 1Department of Pathology, Erasmus MC-University Medical Center Rotterdam, Josephine Nefkens Institute, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands; 2Human Molecular Genetics Laboratory, Prince Henry’s Institute of Medical Research, Clayton, Victoria, Australia; 3Department of Gynaecologic Oncology, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands; 4Department of Clinical Genetics, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands and 5Department of Pediatric Endocrinology, Erasmus MC-University Medical Center Rotterdam, Sophia, Rotterdam, The Netherlands Patients with disorders of sex development (DSD), especially those with gonadal dysgenesis and hypovirilization, are at risk of developing the so-called type II germ cell tumors (GCTs). Both carcinoma in situ and gonadoblastoma (GB) can be the precursor lesion, resulting in a seminomatous or non- seminomatous invasive cancer. SRY mutations residing in the HMG domain are found in 10–15% of 46,XY gonadal dysgenesis cases. This domain contains two nuclear localization signals (NLSs). In this study, we report a unique case of a phenotypical normal woman, diagnosed as a patient with 46,XY gonadal dysgenesis, with an NLS missense mutation, on the basis of the histological diagnosis of a unilateral GB.